Corrigendum: Preclinical profiles of SKB264, a novel anti-TROP2 antibody conjugated to topoisomerase inhibitor, demonstrated promising antitumor efficacy compared to IMMU-132
Year: 2023
Type: erratum
Abstract: In the published article, there was an error in Table 5 as published.The corrected Table 5 and its caption "Payload KL610023 pharmacokinetic parameters in plasma after administrated in cynomolgus monkey (n=4, half male and half female)" appears below.
Source: Frontiers in Oncology
Authors: Yezhe Cheng, Xiaoxi Yuan, Qiang Tian, Xiuying Huang, Yang Chen, Yuzhi Pu, Hu Long, Mingyu Xu, Yafei Ji, Jia Xie, Yuping Tan, Xi Zhao, Hongmei Song
Institution: Kelun Group (China)
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,295
OpenAlex ID: W4389483926